Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research

. 2019; 26(4): 542-5


Does prematurity indicate poor prognosis in the treatment of infant ureteropelvic junction obstruction?

Mirzaman Huseynov; Senol Emre; Rahsan Ozcan; Ayten Ceren Bakir; Nur Canpolat; Mehmet Elicevik; Haluk Emir; Cenk Buyukunal.

Abstract
Aim: To evaluate the outcomes of management of ureteropelvic junction obstruction in premature patients by comparing them to a group of non-premature.
Material and Methods: We reviewed the medical records of 102 patients with isolated hydronephrosis which were referred from pediatric nephrology outpatient clinic or those who admitted directly to pediatric urology clinic under one year of age between the years of 2005 and 2016. Two groups were set up; premature and term. The gestational age, sex, management for ureteropelvic junction obstruction, complications were recorded. Chi-Square, FisherÂ’s and Mann-Whitney-U tests were used for statistical analyzes.
Results: There were 92 patients in the term group and 10 in the premature group. All patients were operated. Preoperative symptoms such as pyonephrosis, renal calculi, and hypertension were relatively common in the premature group. Preoperative low function, postoperative loss of function, and poor outcome were statistically more common in premature patients.
Conclusion: In our limited experience, prematurity is an independent factor associated with UPJO, and it may indicate a poor prognosis. We advocate that this issue should be considered in practice.

Key words: Infant;Hydronephrosis;Ureteropelvic Junction Obstruction;Prematurity;Poor Prognosis



Share this Article


Advertisement
American Journal of Research in Medical Sciences

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons